Drug Patents owned by Noven
1. Drug name - MINIVELLE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9724310 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(5 years from now) | |
| US8231906 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2030
(7 years from now) | |
| EP2310001A2 | NOVEN | Transdermal Estradiol Device And Delivery |
Feb, 2017
(5 years ago) | |
| EP2310001B1 | NOVEN | Transdermal Estradiol Device And Delivery |
Feb, 2017
(5 years ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9730900 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(5 years from now) | |
| US9833419 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(5 years from now) | |
Drugs and Companies using ESTRADIOL ingredient
Treatment: A method for administering estradiol comprising a monolithic transdermal drug delivery system consisting of (i) a backing layer and (ii) a single adhesive polymer matrix layer as claimed in us patent no. 9730900
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.025MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 0.0375MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 0.05MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 0.075MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 0.1MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.